SE443143B - Forfarande for framstellning av arylmalonamido-1-oxadetiacefalosporiner - Google Patents

Forfarande for framstellning av arylmalonamido-1-oxadetiacefalosporiner

Info

Publication number
SE443143B
SE443143B SE7703325A SE7703325A SE443143B SE 443143 B SE443143 B SE 443143B SE 7703325 A SE7703325 A SE 7703325A SE 7703325 A SE7703325 A SE 7703325A SE 443143 B SE443143 B SE 443143B
Authority
SE
Sweden
Prior art keywords
phalosporines
oxadethya
arylmalonamido
procedure
preparation
Prior art date
Application number
SE7703325A
Other languages
English (en)
Swedish (sv)
Other versions
SE7703325L (sv
Inventor
M Narisada
W Nagata
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3340176A external-priority patent/JPS52122386A/ja
Priority claimed from JP5029576A external-priority patent/JPS52133997A/ja
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of SE7703325L publication Critical patent/SE7703325L/
Publication of SE443143B publication Critical patent/SE443143B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7703325A 1976-03-25 1977-03-23 Forfarande for framstellning av arylmalonamido-1-oxadetiacefalosporiner SE443143B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3340176A JPS52122386A (en) 1976-03-25 1976-03-25 Cephalosporin analogous compounds as antibacterials
JP5029576A JPS52133997A (en) 1976-04-30 1976-04-30 Cephalosporin antibiotics

Publications (2)

Publication Number Publication Date
SE7703325L SE7703325L (sv) 1977-09-26
SE443143B true SE443143B (sv) 1986-02-17

Family

ID=26372085

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7703325A SE443143B (sv) 1976-03-25 1977-03-23 Forfarande for framstellning av arylmalonamido-1-oxadetiacefalosporiner

Country Status (19)

Country Link
AR (1) AR224606A1 (xx)
BG (1) BG31074A3 (xx)
CY (1) CY1158A (xx)
DD (1) DD129792A5 (xx)
DE (1) DE2713370C2 (xx)
DK (1) DK161331C (xx)
ES (5) ES457174A1 (xx)
GR (1) GR61146B (xx)
HK (1) HK46882A (xx)
HU (1) HU172720B (xx)
IE (1) IE44794B1 (xx)
IL (1) IL51743A (xx)
MX (1) MX4348E (xx)
NO (2) NO158505C (xx)
NZ (1) NZ183687A (xx)
PT (1) PT66346B (xx)
RO (2) RO78228A (xx)
SE (1) SE443143B (xx)
YU (2) YU44038B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU514377B2 (en) * 1977-02-15 1981-02-05 Shionogi & Co., Ltd. l-OXADETHIACEPHAM COMPOUNDS
US4252953A (en) * 1979-05-01 1981-02-24 Eli Lilly And Company Antibiotic crystalline epimer
JPS60123490A (ja) * 1983-12-07 1985-07-02 Shionogi & Co Ltd マロニルオキサセフェムカルボン酸誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL178005C (nl) * 1972-11-06 1986-01-02 Merck & Co Inc Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking, alsmede werkwijze ter bereiding van een cefalosporine-antibioticum.
US3962232A (en) * 1973-11-05 1976-06-08 Eli Lilly And Company 7-methoxycephalosporins
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives

Also Published As

Publication number Publication date
BG31074A3 (en) 1981-10-15
ES469284A1 (es) 1978-11-16
ES469286A1 (es) 1979-09-16
HK46882A (en) 1982-11-19
DK131277A (da) 1977-09-26
YU44038B (en) 1990-02-28
ES469285A1 (es) 1979-09-16
IL51743A (en) 1980-10-26
DK161331B (da) 1991-06-24
GR61146B (en) 1978-09-27
NZ183687A (en) 1979-01-11
ES469287A1 (es) 1979-09-16
NO158505C (no) 1988-09-21
RO71742A (ro) 1982-02-26
IE44794L (en) 1977-09-25
HU172720B (hu) 1978-11-28
CY1158A (en) 1983-01-28
PT66346B (en) 1978-08-16
NO158505B (no) 1988-06-13
YU44039B (en) 1990-02-28
DE2713370C2 (de) 1994-04-21
DD129792A5 (de) 1978-02-08
YU173783A (en) 1983-12-31
ES457174A1 (es) 1978-08-16
AR224606A1 (es) 1981-12-30
NO862107L (no) 1977-09-27
DE2713370A1 (de) 1977-09-29
NO771023L (no) 1977-09-27
RO78228A (ro) 1982-02-01
IE44794B1 (en) 1982-04-07
PT66346A (en) 1977-04-01
MX4348E (es) 1982-04-05
YU173883A (en) 1983-12-31
SE7703325L (sv) 1977-09-26
DK161331C (da) 1991-12-09

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
SE427838B (sv) Forfarande for framstellning av aromatiska uretaner
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO821847L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE437833B (sv) Forfarande for framstellning av 7-beta-oxiiminoacylcefalosporiner
AR211570A1 (es) Procedimiento de preparacion de nuevos derivados de 8-oxi-5-(2-hidroxi-3-aminopropoxi)-carbostirilo
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE434263B (sv) Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE399252B (sv) Forfarande for framstellnign av antidiuretiskt verkande desamino-asparagin Ÿ4-d-argininŸ8-vasopressin
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7704311L (sv) Forfarande for framstellning av bis-penicillanoyloxi-alkaner
SE7714872L (sv) Forfarande for framstellniong av halogenacylamider
SE7709636L (sv) Forfarande for framstellning av 4-oxokapronitril
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE7701667L (sv) Forfarande for framstellning av cefalosporin-antibiotika
SE7705447L (sv) Forfarande for framstellning av tioetrar
SE443143B (sv) Forfarande for framstellning av arylmalonamido-1-oxadetiacefalosporiner

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7703325-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7703325-6

Format of ref document f/p: F